Contrato de Suministro (CONTR 2025 0000740368)
TED · 461584-2026Award noticeawardedNo deadline given
Value
Estimated€54,925,200 · 54,925,200 EUR
Awarded€31,734,560 · 31,734,560 EUR
WinnerSanofi Aventis, S.A.
Who already wins at this buyer
Firms with recorded awards from Servicio Andaluz de Salud. Servicios Centrales in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| World Medica SLU | 2 | €35,589,830 | 2026-06-17 |
| PRIM SA | 2 | €11,067,365 | 2026-06-17 |
| Pfizer, S.L. | Glaxosmithkline, S.A. | 1 | €60,099,699 | 2026-06-02 |
| Logsa Endomedical SL | MEDTRONIC IBERICA SA | 1 | €21,941,562 | 2026-06-16 |
| Cordis Medical Spain, S.L. | Endocardia España Dispositivos Médicos, S.L. | Evomed S.L. | Grifols Movaco, S.A. | Hospidis S.L. | 1 | €21,358,729 | 2026-06-16 |
Full buyer profile: what Servicio Andaluz de Salud. Servicios Centrales buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
- Acuerdo marco, con una única empresa, por el que se fijan las condiciones para el suministro de tracto sucesivo y precio unitario para la adquisición del medicamento nirsevimab, destinado a los centros sanitarios del Servicio Andaluz de Salud. - Presupuesto total: 31.734.560 € (IVA incluido).